hydrocodone bitartrate
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
48 FDA-registered drug labelers
A-S Medication Solutions
Actavis Pharma, Inc.
Alvogen Inc.
American Health Packaging
Amneal Pharmaceuticals LLC
Amneal Pharmaceuticals of New York LLC
Asclemed USA, Inc.
Aurolife Pharma, LLC
AvPAK
Bryant Ranch Prepack
Camber Pharmaceuticals, Inc.
Cambrex Charles City, Inc
Chattem Chemicals, Inc.
Cranbury Pharmaceuticals, LLC
Direct Rx
Elite Laboratories, Inc.
Epic Pharma, LLC
Eywa Pharma Inc
Genus Lifesciences Inc.
Golden State Medical Supply, Inc.
Granules Pharmaceuticals Inc.
Hikma Pharmaceuticals USA Inc.
KVK-Tech, Inc.
LETCO MEDICAL, LLC
Lupin Pharmaceuticals,Inc.
Medisca Inc.
Noramco, LLC
Novel Laboratories, Inc.
NuCare Pharmaceuticals, Inc.
PAI Holdings, LLC dba PAI Pharma
Pharma Source Direct, Inc.
Professional Compounding Centers of America
Professional Compounding Centers of America dba PCCA
Proficient Rx LP
Purdue Pharma LP
Quality Care Products, LLC
Redpharm Drug
RedPharm Drug, Inc
Rhodes Pharmaceuticals L.P.
Siegfried USA, LLC
SpecGx LLC
Spectrum Laboratory Products, Inc.
ST. MARY'S MEDICAL PARK PHARMACY
Strides Pharma Science Limited
Sun Pharmaceutical Industries, Inc.
Upsher-Smith Laboratories, LLC
Veranova, L.P.
XLCare Pharmaceuticals, Inc.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 10 drug and cosmetic product listings (FDA).
- •Hydrocodone Bitartrate and Acetaminophen
- •Hydrocodone/APAP
- •Hydrocodone Bitartrate and Homatropine Methylbromide
- •Hydrocodone Bitartrate
- •Hydromet
- •Hydrocodone Bitartrate and Ibuprofen
- •Hysingla ER
- •Hycodan
Show all 10
- •Hydrocodone Polistirex and Chlorpheniramine Polistirex extended-release
- •Norco
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
to be discontinued
Homatropine Methylbromide and Hydrocodone Bitartrate Syrup
09/11/2025Chemical Identity
CAS143-71-5
PubChem CID23724881
DTXSIDDTXSID40162277
FormulaC44H64N2O23
Mol. Weight989 g/mol
SMILESCN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(=O)CC4.CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(=O)CC4.C(C(C(=O)O)O)(C(=O)O)O.C(C(C(=O)O)O)(C(=O)O)O.O.O.O.O.O
Data Sources
237248812026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/hydrocodone bitartrate/cids/JSON
Archive: data/sources/pubchem_name/hydrocodone bitartrate.json
CAS 143-71-52026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 143-71-52026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json